12:00 AM
Dec 22, 2008
 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Danube Pharmaceuticals Inc.

New York, N.Y.

Technology: Ion-channel modulator

Disease focus: Ophthalmic

Clinical status: Phase...

Read the full 54 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >